학술논문

Injection intervals in real-world neovascular age-related macular degeneration (nAMD) switch brolucizumab (BROL) patients with at least 12 months of follow-up
Document Type
Journal
Source
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE; JUN 2022, 63 7, 5p.
Subject
Language
English
ISSN
15525783